Jane Street Group LLC Has $117,000 Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)

Jane Street Group LLC lessened its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 68.4% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 12,749 shares of the medical instruments supplier's stock after selling 27,593 shares during the period. Jane Street Group LLC's holdings in AngioDynamics were worth $117,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. SBI Securities Co. Ltd. acquired a new stake in AngioDynamics during the 4th quarter worth $28,000. Bank of New York Mellon Corp grew its holdings in AngioDynamics by 3.2% during the 4th quarter. Bank of New York Mellon Corp now owns 122,676 shares of the medical instruments supplier's stock worth $1,124,000 after acquiring an additional 3,815 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in AngioDynamics by 0.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 329,090 shares of the medical instruments supplier's stock worth $3,014,000 after acquiring an additional 2,270 shares during the period. Principal Financial Group Inc. acquired a new stake in AngioDynamics during the 4th quarter worth $879,000. Finally, Wells Fargo & Company MN grew its holdings in AngioDynamics by 35.4% during the 4th quarter. Wells Fargo & Company MN now owns 23,715 shares of the medical instruments supplier's stock worth $217,000 after acquiring an additional 6,200 shares during the period. Institutional investors and hedge funds own 89.43% of the company's stock.

Analyst Ratings Changes

Separately, HC Wainwright reaffirmed a "buy" rating and set a $16.00 target price (up previously from $15.00) on shares of AngioDynamics in a report on Monday, April 7th.

AngioDynamics Stock Up 0.9%

Shares of ANGO stock opened at $11.06 on Friday. AngioDynamics, Inc. has a 12-month low of $5.47 and a 12-month high of $13.50. The firm has a market capitalization of $449.11 million, a price-to-earnings ratio of -1.96 and a beta of 0.62. The firm has a fifty day moving average of $9.58 and a 200-day moving average of $9.70.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last announced its quarterly earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.16. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The company had revenue of $72.00 million during the quarter, compared to analyst estimates of $70.30 million. The company's revenue for the quarter was down 4.3% compared to the same quarter last year. Research analysts expect that AngioDynamics, Inc. will post -0.37 earnings per share for the current year.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.